Remarkably, when GLP-1-RA and Metformin were administered together to treat PCa cells, a significant reduction in PCa tumor volume was observed, surpassing the effects of a placebo or the drug alone [50]. The gene discussed is GCG; the disease is posterior cortical atrophy.